Abstract CN8
Background
The SARS-CoV-2 pandemic led many patients to face the difficult decision of weighing the risks and benefits associated with traveling to the hospital for cancer treatment. Driven by this context and motivated by the growing demand for safer and more convenient alternatives, we proposed expanding the administration of low-risk neoplastic treatments to the ambulatory setting. This program has been unprecedented in the Autonomous Community of Cantabria thus far, as there is currently no service that administers chemotherapy outside specialized units in the region's reference hospitals.
Methods
A pilot study was conducted to assess the safety and feasibility of administering low-risk antineoplastic treatments at home at the Marqués de Valdecilla University Hospital, in the city of Santander-Cantabria. The study sample consisted of 139 participants between November 2020 and April 2024. For a patient to be selected to receive treatment at home, they had to meet the following inclusion criteria: firstly, be actively undergoing treatment with low-risk antineoplastic drugs, either subcutaneously or intravenously after the third dose; have a residence in Santander and within a 10-kilometer radius; be at home accompanied by a caregiver between 8:00 and 14:00 on the day of treatment; be able to read and write, or alternatively, have a family member or caregiver available to complete satisfaction questionnaires if necessary. Patients were included in the study only after receiving all the information and providing their consent to participate.
Results
A total of 1,334 cycles were infused in 139 patients from December 2020 to January 2024. The average age of the treated population was 65 years, with 37% being male (n=52) and 63% female (n=87). Breast cancer was the most treated pathology at home (n=59), followed by lung cancer (n=35) and colon cancer (n=12). The most administered drug was trastuzumab (n=47), followed by Pembrolizumab (n=32), Bevacizumab (n=19), and Atezolizumab (n=17). During the pilot program, no adverse infusion reactions were recorded at home.
Conclusions
This project represents a step forward in optimizing oncological care, although further exploration of new ways to improve our patients' treatment experience is still needed.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
Instituto de Investigación Valdecilla (IDIVAL).
Funding
IDIVAL, FUPOCAN, AstraZeneca, MSD, Bristol Myers Squibb.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
CN7 - Clinical characteristics of cancer patients with central venous catheter-related infections: Insights from a single centre study
Presenter: Jacopo Bonanni
Session: EONS Poster Display session
Resources:
Abstract
Slides
CN9 - Using the ‘person-based approach’ to adapt and optimise an eLearning resource to equip professionals to support families when a significant adult with children (>18 years) is at end of life with cancer
Presenter: Sarah Sheehan
Session: EONS Poster Display session
Resources:
Abstract
Slides
CN10 - Stress of conscience in healthcare personnel caring for patients at the end of life during the COVID-19 pandemic
Presenter: Maria Larsson
Session: EONS Poster Display session
Resources:
Abstract
Slides
CN11 - The challenges of the multidisciplinary work of nurses in the international department at Gustave Roussy Cancer Campus
Presenter: Zoe Hoyau
Session: EONS Poster Display session
Resources:
Abstract
Slides
CN17 - A multimedia method for pre-test genetic counselling in breast cancer patients: A pilot feasibility study
Presenter: Carmen Wing Han CHAN
Session: EONS Poster Display session
Resources:
Abstract
Slides
CN18 - Perspectives of patients with prostate cancer on self-management support through mHealth and health-coaching
Presenter: Louise Øbro
Session: EONS Poster Display session
Resources:
Abstract
Slides
CN19 - Evaluation of acceptance and perceived barriers to mobile health applications among breast cancer patients and caregivers at the National Cancer Institute, Cairo University
Presenter: Zeinab Abdelwhab
Session: EONS Poster Display session
Resources:
Abstract
Slides
CN20 - Impact of the free information service My Cancer Navigator according to patients and their relatives: An online survey
Presenter: Gabry Kuijten
Session: EONS Poster Display session
Resources:
Abstract
Slides
CN21 - Descriptive and content analysis of breast cancer vlogs on YouTube
Presenter: Nina Morena
Session: EONS Poster Display session
Resources:
Abstract
Slides
CN23 - Development of multidisciplinary DigiCanTrain Digital Competence Framework for cancer care
Presenter: Heli Mikkonen
Session: EONS Poster Display session
Resources:
Abstract
Slides